News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Stemgent Completes Acquisition of Asterand plc (ATD.L)'s Human Tissue Business


8/1/2012 9:51:48 AM

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Stemgent, Inc. announced today that it has completed the acquisition of Asterand Plc’s Human Tissue Business for $9 million. Asterand provides a set of high quality, human-tissue based tools for drug and drug target discovery that is highly complementary to Stemgent’s growing portfolio of innovative research products and services to advance cellular reprograming and stem cell research.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES